fjörD2C skincare brand bringing patented biotech to consumers.
The brand
Fjor is a D2C skincare brand bringing patented biotech to consumers. The founder needed a strategic finance leader to turn an early-stage product into an investable business: unit economics an investor would underwrite, a supply chain that protected margin, operations that could scale, and the reporting infrastructure to make decisions on numbers rather than instinct.
What we did
- Measured and improved CAC. Cut customer acquisition cost by 90% by rationalising marketing strategy to meet investor expectations for unit economics.
- Renegotiated entire supply contract. Increased gross margin to 80% on best seller products and obtained a global exclusive licence to distribute the patented biotechnology.
- Rebuilt operations. Replacing logistics providers, reducing error rates and costs, and enabling branded packaging materials.
- Built financial infrastructure. Set up KPI dashboards, budget tracking, and internal and board reporting to support data-driven decision-making.
- Secured fundraising round. Raised pre-seed funding by developing investor pitch materials and financial model, securing backing from leading early-stage investors such as Apeiron Investment Group (Christian Angermayer).
-90%
80%
Pre-seed